In a multicenter comparative study involving 149 women undergoing uterine artery embolization (UAE) and 60 women undergoing myomectomy, researchers found that both procedures resulted in similar bleeding improvement, uterine volume reduction, uterine fibroid quality-of-life score improvement, and overall quality-of-life score improvement.
In a multicenter comparative study involving 149 women undergoing uterine artery embolization (UAE) and 60 women undergoing myomectomy, researchers found that both procedures resulted in similar bleeding improvement, uterine volume reduction, uterine fibroid quality-of-life score improvement, and overall quality-of-life score improvement.
However, the mean hospital stay for the women receiving UAE was 1 day versus 2.5 days for the myomectomy patients. Time to return to normal activities was 15 days for the UAE group versus 44 days for the myomectomy group, and time to return to work was 10 and 37 days, respectively. At least one adverse event occurred in almost twice as many women receiving myomectomy as in those receiving UAE (40.1% vs. 22.1%, respectively).
But benefits must always be weighed against failures, and researchers in a separate retrospective study calculated a 9.4% failure rate for uterine artery embolization.
The symptoms most often prompting subsequent surgery were recurrent menorrhagia, which occurred in 13 (59.1%) of the women, and persistent abdominal pain, which occurred in five (22.7%) of the women.
Goodwin SC, Bradley LD, Lipman JC, et al. Uterine artery embolization versus myomectomy: a multicenter comparative study. Fertil Steril. 2006;85:14-21.
Huang JY, Kafy S, Dugas A, et al. Failure of uterine fibroid embolization. Fertil Steril. 2006;85:30-35.
Unraveling preeclampsia: Insights into heterogeneity and intravascular inflammation
April 22nd 2024A recent study delved into the intricate clusters of term preeclampsia, shedding light on its diverse manifestations and the pivotal role of intravascular inflammation, paving the way for improved classification and management strategies.
Read More
Personalized opioid protocol for cesarean deliveries: Reduced prescriptions reported
April 19th 2024A recent suggests that implementing a personalized opioid prescription protocol significantly reduces total morphine milligram equivalents and the number of opioid tablets prescribed at discharge following cesarean delivery.
Read More
Long-term mortality risks for women with adverse pregnancy outcomes
April 19th 2024A recent study revealed that women who experience major adverse pregnancy outcomes face heightened long-term mortality risks, shedding light on the need for comprehensive understanding and preventative measures in women's health.
Read More